FOXA1
Hepatocyte nuclear factor 3-alpha
Also known as: FOXA1_HUMAN, HNF3A
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P55317
- Gene
- FOXA1
- Ensembl
- ENSG00000129514
- Chromosome
- 14
- Canonical length
- 472 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nucleoli fibrillar center
OverviewNCBI Gene
This gene encodes a member of the forkhead class of DNA-binding proteins. These hepatocyte nuclear factors are transcriptional activators for liver-specific transcripts such as albumin and transthyretin, and they also interact with chromatin. Similar family members in mice have roles in the regulation of metabolism and in the differentiation of the pancreas and liver. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
472 residues, UniProt reviewed canonical sequence.
>P55317|FOXA1
1 MLGTVKMEGH ETSDWNSYYA DTQEAYSSVP VSNMNSGLGS MNSMNTYMTM NTMTTSGNMT
61 PASFNMSYAN PGLGAGLSPG AVAGMPGGSA GAMNSMTAAG VTAMGTALSP SGMGAMGAQQ
121 AASMNGLGPY AAAMNPCMSP MAYAPSNLGR SRAGGGGDAK TFKRSYPHAK PPYSYISLIT
181 MAIQQAPSKM LTLSEIYQWI MDLFPYYRQN QQRWQNSIRH SLSFNDCFVK VARSPDKPGK
241 GSYWTLHPDS GNMFENGCYL RRQKRFKCEK QPGAGGGGGS GSGGSGAKGG PESRKDPSGA
301 SNPSADSPLH RGVHGKTGQL EGAPAPGPAA SPQTLDHSGA TATGGASELK TPASSTAPPI
361 SSGPGALASV PASHPAHGLA PHESQLHLKG DPHYSFNHPF SINNLMSSSE QQHKLDFKAY
421 EQALQYSPYG STLPASLPLG SASVTTRSPI EPSALEPAYY QGVYSRPVLN TSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FOXA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 70 nTPM
Expression across tissuesHPA
Tissue
- prostate: 70 nTPM
- stomach: 22 nTPM
- liver: 22 nTPM
- breast: 21 nTPM
- urinary bladder: 19 nTPM
- salivary gland: 15 nTPM
Single-cell type
- prostatic glandular cells: 293 nCPM
- breast hormone-responsive cells: 196 nCPM
- prostatic club cells: 164 nCPM
- parietal cells: 159 nCPM
- respiratory secretory cells: 148 nCPM
- urothelial cells: 147 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- midbrain: 7.6 nTPM
- thalamus: 1.5 nTPM
- hypothalamus: 0.7 nTPM
- pons: 0.6 nTPM
- spinal cord: 0.6 nTPM
- medulla oblongata: 0.2 nTPM
ReferencesPubMed · IEDB
Publications for FOXA1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
- Serum Autoantibodies against LRDD, STC1, and FOXA1 as Biomarkers in the Detection of Ovarian Cancer.
2022 · Dis Markers · RCR 0.8 · 10 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.68
- gnomAD pLI
- 0.22
- gnomAD missense Z
- 0.44
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- alveolar secondary septum development
- anatomical structure formation involved in morphogenesis
- anatomical structure morphogenesis
- cell differentiation
- chromatin remodeling
- dopaminergic neuron differentiation
- dorsal/ventral neural tube patterning
- epithelial cell maturation involved in prostate gland development
- epithelial tube branching involved in lung morphogenesis
- glucose homeostasis
- hormone metabolic process
- lung epithelial cell differentiation
- mesenchymal-epithelial cell signaling involved in prostate gland development
- negative regulation of epithelial to mesenchymal transition
- negative regulation of transcription by RNA polymerase II
- neuron fate specification
- Notch signaling pathway
- positive regulation of apoptotic process
- positive regulation of cell-cell adhesion mediated by cadherin
- positive regulation of DNA-binding transcription factor activity
- positive regulation of dopaminergic neuron differentiation
- positive regulation of intracellular estrogen receptor signaling pathway
- positive regulation of miRNA transcription
- positive regulation of mitotic cell cycle
- positive regulation of smoothened signaling pathway
- positive regulation of transcription by RNA polymerase II
- prostate gland epithelium morphogenesis
- prostate gland stromal morphogenesis
- regulation of transcription by RNA polymerase II
- respiratory basal cell differentiation
- response to estradiol
- secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development
- smoothened signaling pathway
Molecular functions
- chromatin binding
- DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- protein domain specific binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- transcription cis-regulatory region binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Fork head domain
- Fork-head N-terminal
- Fork head domain conserved site1
- Forkhead box protein, C-terminal
- Fork head domain conserved site 2
- Winged helix-like DNA-binding domain superfamily
- Winged helix DNA-binding domain superfamily
- Forkhead box domain-containing protein
- Forkhead domain
- Forkhead N-terminal region
- HNF3 C-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FOXA1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FOXA1 as an antibody target. Whether an autoantibody or antibody against FOXA1 could matter depends on whether native FOXA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FOXA1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FOXA1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...